Zobrazeno 1 - 10
of 807
pro vyhledávání: '"Hedskog, C."'
Autor:
Rodriguez L; Gilead Sciences, Inc., Foster City, California, USA., Lee HW; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Li J; Gilead Sciences, Inc., Foster City, California, USA., Martin R; Gilead Sciences, Inc., Foster City, California, USA., Han D; Gilead Sciences, Inc., Foster City, California, USA., Xu S; Gilead Sciences, Inc., Foster City, California, USA., Moshiri J; Gilead Sciences, Inc., Foster City, California, USA., Peinovich N; Gilead Sciences, Inc., Foster City, California, USA., Camus G; Gilead Sciences, Inc., Foster City, California, USA., Perry JK; Gilead Sciences, Inc., Foster City, California, USA., Hyland RH; Gilead Sciences, Inc., Foster City, California, USA., Porter DP; Gilead Sciences, Inc., Foster City, California, USA., Abdelghany M; Gilead Sciences, Inc., Foster City, California, USA., Götte M; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Hedskog C; Gilead Sciences, Inc., Foster City, California, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Dec 19, pp. e0123824. Date of Electronic Publication: 2024 Dec 19.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hedskog C; Gilead Sciences, Inc., Foster City, CA 94404, USA., Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine-Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, 81675 Munich, Germany., Protzer U; German Center for Infection Research (DZIF), Munich Partner Site, 81675 Munich, Germany.; Institute of Virology, Technical University of Munich School of Medicine, 81675 Munich, Germany.; Institute of Virology, Helmholtz Munich, 85764 Munich, Germany., Hoffmann D; German Center for Infection Research (DZIF), Munich Partner Site, 81675 Munich, Germany.; Institute of Virology, Technical University of Munich School of Medicine, 81675 Munich, Germany., Ko C; Institute of Virology, Technical University of Munich School of Medicine, 81675 Munich, Germany.; Institute of Virology, Helmholtz Munich, 85764 Munich, Germany.; Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea., Gottlieb RL; Center for Advanced Heart and Lung Disease, Department of Internal Medicine, Baylor University Medical Center, Dallas, TX 75246, USA.; Baylor Scott & White Research Institute, Dallas, TX 75246, USA.; Department of Internal Medicine, Texas A&M Health Science Center, Dallas, TX 75246, USA.; Department of Internal Medicine, Burnett School of Medicine at TCU, Fort Worth, TX 76109, USA., Askar M; Center for Advanced Heart and Lung Disease, Department of Internal Medicine, Baylor University Medical Center, Dallas, TX 75246, USA.; QU Health and Department of Immunology, College of Medicine, Qatar University, Doha P.O. Box 2713, Qatar., Roestenberg M; Leiden University Medical Center for Infectious Diseases (LUCID), 2333 ZA Leiden, The Netherlands., de Vries JJC; Leiden University Medical Center for Infectious Diseases (LUCID), 2333 ZA Leiden, The Netherlands., Carbo EC; Leiden University Medical Center for Infectious Diseases (LUCID), 2333 ZA Leiden, The Netherlands., Martin R; Gilead Sciences, Inc., Foster City, CA 94404, USA., Li J; Gilead Sciences, Inc., Foster City, CA 94404, USA., Han D; Gilead Sciences, Inc., Foster City, CA 94404, USA., Rodriguez L; Gilead Sciences, Inc., Foster City, CA 94404, USA., Parvangada A; Gilead Sciences, Inc., Foster City, CA 94404, USA., Perry JK; Gilead Sciences, Inc., Foster City, CA 94404, USA., Ferrer R; Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Medicine Department, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Antón A; Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Medicine Department, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Andrés C; Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Medicine Department, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Casares V; Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Medicine Department, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8057 Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland., Huber M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland., McComsey GA; Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 44106, USA., Sadri N; Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 44106, USA., Aberg JA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., van Bakel H; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Porter DP; Gilead Sciences, Inc., Foster City, CA 94404, USA.
Publikováno v:
Viruses [Viruses] 2024 Mar 31; Vol. 16 (4). Date of Electronic Publication: 2024 Mar 31.
Autor:
Ahmed A; Department of Pediatrics, Levine Children's Hospital at Atrium Health, Charlotte, North Carolina.; Wake Forest University School of Medicine, Winston-Salem, North Carolina., Munoz FM; Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.; Texas Children's Hospital, Houston, Texas., Muller WJ; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Agwu A; Division of Infectious Diseases, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Kimberlin DW; University of Alabama at Birmingham, Birmingham, Alabama., Galli L; Department of Health Sciences, University of Florence; Pediatric Infectious Diseases Unit, Meyer Children's University Hospital, IRCCS, Florence, Italy., Deville JG; Division of Infectious Diseases, Department of Pediatrics, University of California, Los Angeles, California., Sue PK; Division of Infectious Diseases, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas., Mendez-Echevarria A; Servicio de Pediatría, Enfermedades Infecciosas y Tropicales, Hospital Universitario La Paz, Madrid, Spain.; Centro de Investigación en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Humeniuk R; Gilead Sciences, Inc., Foster City, California., Guo S; Gilead Sciences, Inc., Foster City, California., Rodriguez L; Gilead Sciences, Inc., Foster City, California., Han D; Gilead Sciences, Inc., Foster City, California., Hedskog C; Gilead Sciences, Inc., Foster City, California., Maxwell H; Gilead Sciences, Inc., Foster City, California., Palaparthy R; Gilead Sciences, Inc., Foster City, California., Kersey K; Gilead Sciences, Inc., Foster City, California., Rojo P; Hospital Universitario12 de Octubre, Madrid, Spain.; Instituto de Investigación 12 de Octubre, Madrid, Spain.; Universidad Complutense, Madrid, Spain.
Publikováno v:
Pediatrics [Pediatrics] 2024 Mar 01; Vol. 153 (3).
Autor:
Hedskog C; Gilead Sciences, Inc, Foster City, California, USA., Rodriguez L; Gilead Sciences, Inc, Foster City, California, USA., Roychoudhury P; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Huang ML; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA., Jerome KR; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hao L; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA., Ireton RC; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA., Li J; Gilead Sciences, Inc, Foster City, California, USA., Perry JK; Gilead Sciences, Inc, Foster City, California, USA., Han D; Gilead Sciences, Inc, Foster City, California, USA., Camus G; Gilead Sciences, Inc, Foster City, California, USA., Greninger AL; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, USA., Porter DP; Gilead Sciences, Inc, Foster City, California, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2023 Nov 02; Vol. 228 (9), pp. 1263-1273.
Autor:
Chang S; Gilead Sciences, Inc., Foster City, California, USA., Hedskog C; Gilead Sciences, Inc., Foster City, California, USA., Parhy B; Gilead Sciences, Inc., Foster City, California, USA., Martin R; Gilead Sciences, Inc., Foster City, California, USA., Mo H; Gilead Sciences, Inc., Foster City, California, USA., Maiorova E; Gilead Sciences, Inc., Foster City, California, USA., Zoulim F; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France.; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France.; Hospices Civils de Lyon (HCL), Lyon, France.
Publikováno v:
Journal of viral hepatitis [J Viral Hepat] 2023 Jan; Vol. 30 (1), pp. 29-38. Date of Electronic Publication: 2022 Oct 17.
Autor:
Mackman RL; Medicinal Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Kalla RV; Medicinal Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Babusis D; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Pitts J; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Barrett KT; Formulation and Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Chun K; Medicinal Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Du Pont V; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Rodriguez L; Clinical Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Moshiri J; Clinical Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Xu Y; Biochemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Lee M; Biology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Lee G; Biology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Bleier B; Formulation and Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Nguyen AQ; Formulation and Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., O'Keefe BM; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Ambrosi A; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Cook M; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Yu J; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Dempah KE; Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Bunyan E; Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Riola NC; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Lu X; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Liu R; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Davie A; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Hsiang TY; Center for Innate Immunity and Immune Disease, Department of Immunology, School of Medicine, University of Washington, Seattle, Washington 98109 United States., Dearing J; Lovelace Biomedical Research Institute, 2425 Ridgecrest Drive Southeast, Albuquerque, New Mexico 87108 United States., Vermillion M; Lovelace Biomedical Research Institute, 2425 Ridgecrest Drive Southeast, Albuquerque, New Mexico 87108 United States., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, School of Medicine, University of Washington, Seattle, Washington 98109 United States., Niedziela-Majka A; Biology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Feng JY; Biochemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Hedskog C; Clinical Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Bilello JP; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Subramanian R; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Cihlar T; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Sep 14; Vol. 66 (17), pp. 11701-11717. Date of Electronic Publication: 2023 Aug 19.
Autor:
Brown SM; Intermountain Healthcare and the University of Utah School of Medicine, Murray, UT, USA., Katz MJ; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ginde AA; University of Colorado School of Medicine, Aurora, CO, USA., Juneja K; Gilead Sciences, Foster City, CA, USA., Ramchandani M; Gilead Sciences, Foster City, CA, USA., Schiffer JT; Fred Hutchinson Cancer Center and the University of Washington School of Medicine, Seattle, WA, USA., Vaca C; The Nuren Medical and Research Center, Miami, FL, USA., Gottlieb RL; Baylor University Medical Center and Baylor Scott & White Research Institute, Dallas, TX, USA., Tian Y; Gilead Sciences, Foster City, CA, USA., Elboudwarej E; Gilead Sciences, Foster City, CA, USA., Hill JA; Fred Hutchinson Cancer Center and the University of Washington School of Medicine, Seattle, WA, USA., Gilson R; University College London Hospitals, London, UK., Rodriguez L; Gilead Sciences, Foster City, CA, USA., Hedskog C; Gilead Sciences, Foster City, CA, USA., Chen S; Gilead Sciences, Foster City, CA, USA., Montezuma-Rusca JM; Gilead Sciences, Foster City, CA, USA., Osinusi A; Gilead Sciences, Foster City, CA, USA., Paredes R; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol and irsiCaixa AIDS Research Institute, Carretera de Canyet, s/n, 08916, Barcelona, Catalonia, Spain. rparedes@irsicaixa.es.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2023 Apr; Vol. 12 (4), pp. 1189-1203. Date of Electronic Publication: 2023 Apr 19.
Autor:
Mo, H.1, Hedskog, C.1, Svarovskaia, E.1, Sun, S. ‐ C.1, Jacobson, I. M.2, Brainard, D. M.1, McHutchison, J. G.1, Miller, M. D.1
Publikováno v:
Journal of Viral Hepatitis. Aug2016, Vol. 23 Issue 8, p644-651. 8p.
Autor:
Hedskog, C.1, Dvory‐Sobol, H.1, Gontcharova, V.1, Martin, R.1, Ouyang, W.1, Han, B.1, Gane, E. J.2, Brainard, D.1, Hyland, R. H.1, Miller, M. D.1, Mo, H.1, Svarovskaia, E.1
Publikováno v:
Journal of Viral Hepatitis. Nov2015, Vol. 22 Issue 11, p871-881. 11p.